News & Updates
Showing Pharmacy articles
Showing
Show Multimedia Only

Pivotal phase III trial shows Tx potential of oral carbapenem for cUTI or acute pyelonephritis
20 Nov 2025
byAudrey Abella
Results from the phase III PIVOT-PO study demonstrate the potential of tebipenem pivoxil hydrobromide (TBP-PI) as an effective oral carbapenem antibiotic for the treatment of complicated urinary tract infections (cUTI).








